The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Sandimmun 100 mg/ml concentrate for oral solution



Novartis Ireland LimitedPA0896/027/001

Main Information

Trade NameSandimmun 100 mg/ml concentrate for oral solution
Active SubstancesCiclosporin
Dosage FormConcentrate for oral solution
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/027/001

Group Information

ATC CodeL04AD Calcineurin inhibitors
L04AD01 ciclosporin

Status

License statusAuthorised
Licence Issued07/05/1984
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThe product shall not be used later than 2 months after first opening.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back